173 related articles for article (PubMed ID: 23836138)
21. Reduced fetal growth in methadone-maintained pregnancies is not fully explained by smoking or socio-economic deprivation.
Mactier H; Shipton D; Dryden C; Tappin DM
Addiction; 2014 Mar; 109(3):482-8. PubMed ID: 24321028
[TBL] [Abstract][Full Text] [Related]
22. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome.
Wachman EM; Newby PK; Vreeland J; Byun J; Bonzagni A; Bauchner H; Philipp BL
J Addict Med; 2011 Dec; 5(4):293-9. PubMed ID: 21857233
[TBL] [Abstract][Full Text] [Related]
23. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
24. Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine.
Sarfi M; Martinsen H; Bakstad B; Røislien J; Waal H
Early Hum Dev; 2009 Dec; 85(12):773-8. PubMed ID: 19931991
[TBL] [Abstract][Full Text] [Related]
25. Congenital nystagmus in two infants born from mothers exposed to methadone during pregnancy.
Tinelli F; Gamucci A; Battini R; Cioni G
Ital J Pediatr; 2013 Jul; 39():40. PubMed ID: 23822191
[TBL] [Abstract][Full Text] [Related]
26. [Validity of a maternal alcohol consumption questionnaire in detecting prenatal exposure].
Manich A; Velasco M; Joya X; García-Lara NR; Pichini S; Vall O; García-Algar O
An Pediatr (Barc); 2012 Jun; 76(6):324-8. PubMed ID: 22104595
[TBL] [Abstract][Full Text] [Related]
27. Testing ethylglucuronide in maternal hair and nails for the assessment of fetal exposure to alcohol: comparison with meconium testing.
Morini L; Marchei E; Tarani L; Trivelli M; Rapisardi G; Elicio MR; Ramis J; Garcia-Algar O; Memo L; Pacifici R; Groppi A; Danesino P; Pichini S
Ther Drug Monit; 2013 Jun; 35(3):402-7. PubMed ID: 23666568
[TBL] [Abstract][Full Text] [Related]
28. Dose-response and time-response analysis of total fatty acid ethyl esters in meconium as a biomarker of prenatal alcohol exposure.
Kwak HS; Han JY; Choi JS; Ahn HK; Kwak DW; Lee YK; Koh SY; Jeong GU; Velázquez-Armenta EY; Nava-Ocampo AA
Prenat Diagn; 2014 Sep; 34(9):831-8. PubMed ID: 24691675
[TBL] [Abstract][Full Text] [Related]
29. Addiction in pregnancy.
Keegan J; Parva M; Finnegan M; Gerson A; Belden M
J Addict Dis; 2010 Apr; 29(2):175-91. PubMed ID: 20407975
[TBL] [Abstract][Full Text] [Related]
30. [Substitution treatment of drug addicts during pregnancy: consequences for the children?].
Sandtorv L; Reigstad H; Bruarøy S; Elgen I; Laegreid LM
Tidsskr Nor Laegeforen; 2009 Feb; 129(4):287-90. PubMed ID: 19219093
[TBL] [Abstract][Full Text] [Related]
31. [Alternative biological materials to detect prenatal exposure to drugs of abuse in the third trimester of pregnancy].
García-Serra J; Ramis J; Simó S; Joya X; Pichini S; Vall O; García-Algar O
An Pediatr (Barc); 2012 Nov; 77(5):323-8. PubMed ID: 22513392
[TBL] [Abstract][Full Text] [Related]
32. Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants.
Miles J; Sugumar K; Macrory F; Sims DG; D'Souza SW
Child Care Health Dev; 2007 Mar; 33(2):206-12. PubMed ID: 17291325
[TBL] [Abstract][Full Text] [Related]
33. Neonatal outcome in infants with evidence of fetal exposure to opiates, cocaine, and cannabinoids.
Nair P; Rothblum S; Hebel R
Clin Pediatr (Phila); 1994 May; 33(5):280-5. PubMed ID: 8050257
[TBL] [Abstract][Full Text] [Related]
34. Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol.
Morini L; Marchei E; Vagnarelli F; Garcia Algar O; Groppi A; Mastrobattista L; Pichini S
Forensic Sci Int; 2010 Mar; 196(1-3):74-7. PubMed ID: 20060246
[TBL] [Abstract][Full Text] [Related]
35. [Detection of drugs in meconium].
Dahlem P; Bucher HU; Ursprung T; Mieth D; Gautschi K
Monatsschr Kinderheilkd; 1992 Jun; 140(6):354-6. PubMed ID: 1640947
[TBL] [Abstract][Full Text] [Related]
36. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal.
Doberczak TM; Kandall SR; Friedmann P
Obstet Gynecol; 1993 Jun; 81(6):936-40. PubMed ID: 8497359
[TBL] [Abstract][Full Text] [Related]
37. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
[TBL] [Abstract][Full Text] [Related]
38. Outcome in infants exposed to methadone in utero.
McGlone L; Mactier H; MacKinnon JR
BMJ; 2008 Sep; 337():a1774. PubMed ID: 18812375
[No Abstract] [Full Text] [Related]
39. The incidence of prenatal alcohol exposure in Montevideo Uruguay as determined by meconium analysis.
Hutson JR; Magri R; Gareri JN; Koren G
Ther Drug Monit; 2010 Jun; 32(3):311-7. PubMed ID: 20445483
[TBL] [Abstract][Full Text] [Related]
40. Determination of the prevalence of drug misuse by meconium analysis.
Williamson S; Jackson L; Skeoch C; Azzim G; Anderson R
Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F291-2. PubMed ID: 16790733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
